Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis
NCT ID: NCT02123628
Last Updated: 2014-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
40 participants
INTERVENTIONAL
2007-06-30
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis (CHRONOS-2)
NCT05074147
Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections
NCT02378493
Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis
NCT02168816
Diabetic Foot Infection Antibiotic Study
NCT01539811
Pathogenicity Factors of Staphylococcus Pettenkoferi in Foot Wounds and Osteitis in Diabetic Patients
NCT06688084
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
antibiotic therapy
patients are treated with a 6 week-duration of antibiotic therapy :
* Rifampin IP and PO twice daily, 10mg/kg /12H
* Levofloxacin IV and PO 500-750mg once daily
* Doxycycline PO 200mg once daily
* Trimethoprim- sulfamethoxazole IV and PO 800/160mg thrice daily
* Fusidic acid PO 500mg twice daily
* Linezolid IV and PO 600mg twice daily
* Ciprofloxacin IV and PO 750to 1000mg/12h
* Cefotaxime IV 100mg/kg in three IV infusions daily
* Ceftriaxone IV,intramuscularly or subcutaneously 2g once daily
* Cefepime IV ou intra-muscularly 2g /8-12h
duration of the antibiotic therapy
12 week-duration of antibiotic therapy
patients are treated with a 12 week-duration of antibiotic therapy :
* Rifampin IP and PO twice daily, 10mg/kg /12H
* Levofloxacin IV and PO 500-750mg once daily
* Doxycycline PO 200mg once daily
* Trimethoprim- sulfamethoxazole IV and PO 800/160mg thrice daily
* Fusidic acid PO 500mg twice daily
* Linezolid IV and PO 600mg twice daily
* Ciprofloxacin IV and PO 750to 1000mg/12h
* Cefotaxime IV 100mg/kg in three IV infusions daily
* Ceftriaxone IV,intramuscularly or subcutaneously 2g once daily
* Cefepime IV ou intra-muscularly 2g /8-12h
duration of the antibiotic therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
duration of the antibiotic therapy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tourcoing Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric M Senneville, MD, PhD
Role: STUDY_DIRECTOR
Dron Hospital of Tourcoing France
Alina Tone, MD
Role: PRINCIPAL_INVESTIGATOR
Dron Hospital Tourcoing France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dron Hospital
Tourcoing, Nord, France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tone A, Nguyen S, Devemy F, Topolinski H, Valette M, Cazaubiel M, Fayard A, Beltrand E, Lemaire C, Senneville E. Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study. Diabetes Care. 2015 Feb;38(2):302-7. doi: 10.2337/dc14-1514. Epub 2014 Nov 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2006-00625-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.